Interferon - The magic bullet to prevent hepatocellular carcinoma recurrence after resection?

被引：33

作者：

Clavien, Pierre-A. ^{[1
]}

机构：

[1] Univ Zurich Hosp, Dept Visceral & Transplant Surg, Swiss HPB Ctr, CH-8091 Zurich, Switzerland

来源：

ANNALS OF SURGERY | 2007年 / 245卷 / 06期

关键词：

D O I：

10.1097/SLA.0b013e31805d0788

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：843 / 845

页数：3

共 26 条

[1] Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma [J].

Boucher, E ;

Corbinais, S ;

Rolland, Y ;

Bourguet, P ;

Guyader, D ;

Boudjema, K ;

Meunier, B ;

Raoul, JL .

HEPATOLOGY, 2003, 38 (05) :1237-1241

[2] Postresectional adjuvant intraportal chemotherapy in patients with hepatocellular carcinoma: A case-control study [J].

Chau, Gar-Yang ;

Lui, Wing-Yiu ;

Tsay, Shyh-Haw ;

Chao, Yee ;

King, Kuang-Liang ;

Wu, Chew-Wun .

ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (10) :1329-1337

[3] Third Forum on Liver Transplantation - Living donor liver transplantation. Who needs it? How to do it? Who should do it? [J].

Clavien, PA .

JOURNAL OF HEPATOLOGY, 2005, 43 (01) :11-12

[4] Medical progress: Strategies for safer liver surgery and partial liver transplantation [J].

Clavien, Pierre-Alain ;

Petrowsky, Henrik ;

DeOliveira, Michelle L. ;

Graf, Rolf .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1545-1559

[5] Prevention of hepatocellular carcinoma [J].

Colombo, M ;

Donato, MF .

SEMINARS IN LIVER DISEASE, 2005, 25 (02) :155-161

[6] Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation? No, never [J].

Hiatt, JR ;

Carmody, IC ;

Busuttil, RW .

JOURNAL OF HEPATOLOGY, 2005, 43 (04) :573-577

[7] Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor - A prospective randomized study of hepatitis C virus-related liver cancer [J].

Ikeda, K ;

Arase, Y ;

Saitoh, S ;

Kobayashi, M ;

Suzuki, Y ;

Suzuki, F ;

Tsubota, A ;

Chayama, K ;

Murashima, N ;

Kumada, H .

HEPATOLOGY, 2000, 32 (02) :228-232

[8] Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy [J].

Kubo, S ;

Nishiguchi, S ;

Hirohashi, K ;

Tanaka, H ;

Shuto, T ;

Kinoshita, H .

BRITISH JOURNAL OF SURGERY, 2002, 89 (04) :418-422

[9] Effects of long-term postoperative interferon-α therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma -: A randomized, controlled trial [J].

Kubo, S ;

Nishiguchi, S ;

Hirohashi, K ;

Tanaka, H ;

Shuto, T ;

Yamazaki, O ;

Shiomi, S ;

Tamori, A ;

Oka, H ;

Igawa, S ;

Kuroki, T ;

Kinoshita, H .

ANNALS OF INTERNAL MEDICINE, 2001, 134 (10) :963-967

[10] Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial [J].

Lau, WY ;

Leung, TWT ;

Ho, SKW ;

Chan, M ;

Machin, D ;

Lau, J ;

Chan, ATC ;

Yeo, W ;

Mok, TSK ;

Yu, SCH ;

Leung, NWY ;

Johnson, PJ .

LANCET, 1999, 353 (9155) :797-801

← 1 2 3 →